FOXO4-DRI Side Effects: Safety Signals and Warnings
FOXO4-DRI safety concerns are compound-specific. The main listed side effects are Transient mild diarrhea (observed in mice), Potential off-target apoptosis at very high doses, and Unknown long-term effects. The main warning signals are No human trials have been conducted, Self-administration is strongly discouraged due to lack of safety data, and Potential risk of excessive cell death if dosing is not carefully controlled.
Direct Answer
Evidence for FOXO4-DRI is too preliminary to support a research protocol with confidence. All published data is from a single mouse model study, with no human pharmacokinetics, no safety data, and no independent replication. The senolytic concept is scientifically compelling, but this specific compound has not progressed to human investigation. Of the Anti-Aging & Longevity compounds in this library, NAD+ precursors have substantially more human evidence.
- Evidence grade
- Level D
- Research status
- Preclinical
- Category
- Anti-Aging & Longevity
- Evidence context
- Senolytic mechanistic research, p21-mediated senescence models (mouse only)
Reported Side Effects
- Transient mild diarrhea (observed in mice)
- Potential off-target apoptosis at very high doses
- Unknown long-term effects
Warnings
- No human trials have been conducted
- Self-administration is strongly discouraged due to lack of safety data
- Potential risk of excessive cell death if dosing is not carefully controlled
- May interfere with wound healing by eliminating beneficial senescent cells involved in tissue repair
Known or Plausible Interactions
- Other senolytic agents (dasatinib, quercetin - potential additive effects)
- Immunosuppressants (altered immune clearance of apoptotic debris)
- Anticoagulants (unknown interaction profile)
Regulatory Context
Research chemical; not approved for human use in any jurisdiction.
Evidence Snapshot
| Evidence grade | Level D |
|---|---|
| Research status | Preclinical |
| Best supported outcomes | Senescent Cell Clearance (Level D), Organ Function Restoration (Level D), and Physical Performance (Level D) |
| Primary citation count | 2 |
| Last reviewed | 2026-08-27 |
Quick Answers
What are the side effects of FOXO4-DRI?
FOXO4-DRI safety concerns are compound-specific. The main listed side effects are Transient mild diarrhea (observed in mice), Potential off-target apoptosis at very high doses, and Unknown long-term effects. The main warning signals are No human trials have been conducted, Self-administration is strongly discouraged due to lack of safety data, and Potential risk of excessive cell death if dosing is not carefully controlled.
What is the evidence level for FOXO4-DRI?
FOXO4-DRI is rated Level D. Its current research status is Preclinical.
What is FOXO4-DRI best known for?
Senolytic mechanistic research, p21-mediated senescence models (mouse only).
Where can I read the full FOXO4-DRI evidence review?
The full evidence review is available at https://examinepeptides.com/library/foxo4-dri.
Related Guides
How to Cite This Page
ExaminePeptides. "FOXO4-DRI Side Effects: Safety Signals and Warnings." Last reviewed 2026-08-27. https://examinepeptides.com/answers/foxo4-dri-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.